Xilio Therapeutics
Damiano Fantini has several years of work experience in the field of research and development. Damiano currently holds the position of Associate Director at Xilio Therapeutics, Inc. since January 2023, where they previously served as a Principal Scientist from June 2021 to February 2023. Prior to their role at Xilio Therapeutics, Inc., Damiano worked at Eli Lilly and Company as a Research Scientist from November 2018 to May 2021. Before joining Eli Lilly, they held the position of Postdoctoral Research Fellow at Northwestern University from June 2016 to November 2018. Damiano also gained experience as a Postdoctoral Research Scholar at the University of Illinois at Chicago from April 2013 to May 2016. Damiano started their career as a Postdoctoral Fellow at CEA - Commissariat à l'énergie atomique et aux énergies alternatives from June 2010 to September 2012.
Damiano Fantini's education history begins with their Bachelor of Science (Laurea Triennale) in Biotechnology from Università degli Studi di Trieste, which they obtained between 2001 and 2004. Damiano then pursued a Master of Science (Laurea Magistrale) in Medical Biotechnology from the same institution, completing it from 2004 to 2006.
Following their master's degree, Fantini enrolled at Università degli Studi di Udine and obtained their Doctor of Philosophy (Ph.D.) in Biomedical and Biotechnological Sciences between 2007 and 2010.
In terms of certifications, Fantini has obtained several from edX, including "Advanced Statistics for the Life Sciences (edX Verified Certificate - HarvardX - PH525.3x)", "Case Study: ChIP-seq data analysis (edX Verified Certificate - HarvardX - PH525.7x)", "Case Study: RNA-seq data analysis (edX Verified Certificate - HarvardX - PH525.5x)", "Case Study: Variant Discovery and Genotyping (edX Verified Certificate - HarvardX - PH525.6x)", "Case study: DNA methylation data analysis (edX Verified Certificate - HarvardX - PH525.8x)", "Introduction to Bioconductor (edX Verified Certificate - HarvardX - PH525.4x)", "Matrix Algebra and Linear Models (edX Verified Certificate - HarvardX - PH525.2x)", and "Statistics and R for the Life Sciences (edX Verified Certificate - HarvardX - PH525.1x)". Additionally, they obtained a certification in Machine Learning from Coursera in July 2018.
Based on the provided information, it can be concluded that Fantini has a strong educational background, with a Ph.D. in Biomedical and Biotechnological Sciences and multiple certifications in various areas of study related to the life sciences.